Viewing Study NCT06922656


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2025-12-27 @ 3:58 PM
Study NCT ID: NCT06922656
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-29
First Post: 2025-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration?
Sponsor: Dasman Diabetes Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module